The reaction of
fac-[IrH2(NCCH3)3(PiPr3)]BF4
(1) with potassium pyrazolate gave the
binuclear 34-electron complex
[Ir2(μ-H)(μ-Pz)2H3(NCCH3)(PiPr3)2]
(2). The structure of 2 was
determined by X-ray diffraction. An electrostatic potential
calculation located three terminal
hydride ligands and one hydride bridging both iridium centers. The
feasibility of this
arrangement was studied by EHMO calculations. The spectroscopic
data for 2 show that
the complex is rigid in solution on the NMR time scale. In
solution, the acetonitrile ligand
of 2 dissociates. The activation parameters for this
dissociation process in toluene-d
8
are
ΔH
⧧ = 20.9 ± 0.6 kcal
mol-1 and ΔS
⧧ =
2.5 ± 1.3 e.u. Reaction of 2 with various
Lewis
bases (L) gives the substitution products
[Ir2(μ-H)(μ-Pz)2H3(L)(PiPr3)2]
(L = C2H4 (3), CO
(4), HPz (5)). The reaction of complex
5 with C2H4 yields the ethyl
derivative [Ir2(μ-H)(μ-Pz)2(C2H5)H2(HPz)(PiPr3)2]
(6); this reaction is reversible. Complexes
2 and 3 react with
CHCl3 to give CH2Cl2 and the
compounds
[Ir2(μ-H)(μ-Pz)2H2(Cl)(L)(PiPr3)2]
(L = NCCH3 (7),
C2H4 (8)). In the
1H NMR spectra of 2
−
6,
the signal of the bridging hydride ligand shows
two very different J
HP couplings; in contrast,
for the chloride complexes 7 and 8, two
equal
J
HP couplings are observed. NOE and
T
1 measurements lead to the conclusion that
in
complexes 2
−
6 the hydride bridges
the iridium centers in a nonsymmetric fashion, whereas
for 7 and 8 the bridge is symmetrical. This
structural feature largely influences the
reactivity. Compounds 2 and 3 undergo H/D
exchange under a D2 atmosphere. Analysis
of
the isotopomeric mixtures of 2 reveals downfield isotopic
shifts in the 31P{1H} NMR
spectrum.
Downfield as well as high-field shifts are found for the hydride
signals in the 1H NMR
spectrum of partially deuterated 2. Further reaction of
3 with H2 gave ethane and the
dihydrogen complex
[Ir2(μ-H)(μ-Pz)2H3(η2-H2)(PiPr3)2]
(9). Under a deficiency of H2, in
toluene-d
8 solution, 9 undergoes H/D
scrambling with the participation of the solvent. It has
also
been found that under H2 complex 3 catalyzes the
hydrogenation of cyclohexene.
Mesogenic (pyrazolato)gold complexes of formula
[Au(pz)]3 (pz =
3,5-bis(3‘,4‘-di-n-decyloxyphenyl)pyrazole
(1),
3-(3‘,4‘,5‘-tri-n-decyloxyphenyl)-5-(3‘‘,4‘‘-di-n-decyloxyphenyl)pyrazole
(2),
3-(2‘,3‘,4‘-tri-n-decyloxyphenyl)-5-(3‘‘,4‘‘,5‘‘-tri-n-decyloxyphenyl)pyrazole
(3),
3,5-bis(3‘,4‘,5‘-tri-n-decyloxyphenyl)pyrazole
(4)) have been prepared
by reaction of the potassium salts of the nonmesogenic pyrazolate
ligands with [AuCl(tht)] (tht = tetrahydrothiophene) in a 1:1 molar ratio. All these compounds show
columnar mesophases that remain stable, at room
temperature, for long periods of time. The formation of isomers
for the nonsymmetrical derivativesdetected by
spectroscopic studiesare suggested to be responsible for the subtle
changes observed in the transition temperatures.
Powder X-ray diffraction measurements show clearly that the
supramolecular columnar arrangement appears in
the crystalline solids as well as in the mesomorphic phase. An
analogue of the mesogenic trinuclear complexes
1
−
4, having a methoxy group at the
phenyl substituents of the pyrazolate ligands,
[Au{3,5-(MeOPh)2Pz}]3
(5),
has been synthesized and characterized by an X-ray single-crystal
diffraction experiment. The molecular structure
of 5 is based on a nine-membered metallacycle core. The
whole molecule exhibits a rough planarity that favors
a crystalline structure formed from columnar arrangements of trinuclear
complexes. A simple and clear relationship
could be established between the solid-state crystal structure of
5 and the X-ray-deduced structure of the
mesophases.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.